|
53
|
240
|
5t0hM |
Structural basis for dynamic regulation of the human 26s proteasome |
|
35
|
199
|
5t0hQ |
Structural basis for dynamic regulation of the human 26s proteasome |
|
37
|
234
|
5t0hK |
Structural basis for dynamic regulation of the human 26s proteasome |
|
41
|
233
|
5t0gH |
Structural basis for dynamic regulation of the human 26s proteasome |
|
41
|
204
|
5t0hP |
Structural basis for dynamic regulation of the human 26s proteasome |
|
57
|
204
|
5cghI |
Yeast 20s proteasome beta5-g48c mutant in complex with alpha-chloroacetamide 5 |
|
61
|
196
|
5nifH |
Yeast 20s proteasome in complex with blm-pep activator |
|
57
|
222
|
5cghH |
Yeast 20s proteasome beta5-g48c mutant in complex with alpha-chloroacetamide 5 |
|
66
|
233
|
5cgiM |
Yeast 20s proteasome beta5-g48c mutant in complex with onx 0914 |
|
69
|
241
|
5nifA |
Yeast 20s proteasome in complex with blm-pep activator |
|
56
|
204
|
5nifJ |
Yeast 20s proteasome in complex with blm-pep activator |
|
58
|
204
|
5cgiI |
Yeast 20s proteasome beta5-g48c mutant in complex with onx 0914 |
|
67
|
240
|
5cggC |
Yeast 20s proteasome beta5-g48c mutant in complex with alpha-chloroacetamide 1 |
|
70
|
243
|
5nifE |
Yeast 20s proteasome in complex with blm-pep activator |
|
54
|
243
|
5mpaG |
26s proteasome in presence of atp (s2) |
|
57
|
222
|
5cgiH |
Yeast 20s proteasome beta5-g48c mutant in complex with onx 0914 |
|
72
|
243
|
5cgiF |
Yeast 20s proteasome beta5-g48c mutant in complex with onx 0914 |
|
51
|
250
|
5mp9B |
26s proteasome in presence of atp (s1) |
|
62
|
211
|
5l5zK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
42
|
196
|
5mp91 |
26s proteasome in presence of atp (s1) |
|
65
|
240
|
5l5iC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
71
|
243
|
5l5wF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
64
|
233
|
5le5D |
Native human 20s proteasome at 1.8 angstrom |
|
76
|
248
|
5lf6B |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
68
|
240
|
5l5uC |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
244
|
5lajB |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
250
|
5l65A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
62
|
233
|
5lf0D |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
69
|
250
|
5l5rA |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
65
|
240
|
5lajC |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
237
|
5lf6C |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
56
|
195
|
5l5yJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
59
|
196
|
5laiN |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
239
|
5lf3F |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
53
|
229
|
5mp97 |
26s proteasome in presence of atp (s1) |
|
60
|
196
|
5l6aN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
242
|
5l5bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
59
|
226
|
5l67H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
55
|
204
|
5lexI |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
61
|
233
|
5lf6D |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
195
|
5l5tJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
240
|
5laiC |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
241
|
5lajG |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
66
|
216
|
5lf6M |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
56
|
204
|
5l5aI |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
67
|
240
|
5l5fC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
204
|
5l64I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
204
|
5laiI |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
62
|
231
|
5l62E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
63
|
231
|
5l69E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
